SEC Wins Trial in Novel ‘Shadow' Insider Trading Crackdown [BNN Bloomberg (Canada)]
Incyte Corporation (INCY)
Last incyte corporation earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
incyte.com/ir/investor-overview.aspx
Company Research
Source: BNN Bloomberg
from using non-public information about their own company to place bets on rival stocks. The closely watched two-week San Francisco civil trial was the regulator's first enforcement action targeting so-called shadow trading, a widespread phenomenon that researchers say has gone largely unchecked. Congress has never explicitly defined insider trading, leaving courts to decide when the SEC oversteps its authority. Friday's verdict comes as SEC enforcement chief Gurbir Grewal has brought cases that have pushed the agency into new territory — and also drawn criticism that the regulator has stretched its powers beyond its jurisdiction. It followed a big victory for the SEC's efforts to assert greater control over cryptocurrency when a jury in New York hours earlier found Terraform Labs Pte. and co-founder Do Kwon liable for fraud over the firm's 2022 collapse. In the San Francisco case, the SEC argued that former Medivation Inc. executive Matthew Panuwat broke the law when he learned
Show less
Read more
Impact Snapshot
Event Time:
INCY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INCY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INCY alerts
High impacting Incyte Corporation news events
Weekly update
A roundup of the hottest topics
INCY
News
- Repare Therapeutics appoints Steven Stein to its board of directors [Seeking Alpha]Seeking Alpha
- Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors [Yahoo! Finance]Yahoo! Finance
- Incyte Pharmaceuticals: Cheap Enough Now (Rating Upgrade) [Seeking Alpha]Seeking Alpha
- Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX [Yahoo! Finance]Yahoo! Finance
- Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $92.00 to $84.00. They now have an "outperform" rating on the stock.MarketBeat
INCY
Earnings
- 2/13/24 - Beat
INCY
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- 4/29/24 - Form DEF
- INCY's page on the SEC website